The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, is based on a tripartite international partnership between the University of Copenhagen, Denmark, Leiden University Medical Centre, The Netherlands and the Murdoch Children’s Research Institute, Australia.
Together, these three sites combine to provide research excellence as well as opportunities and experience around stem cell disease modeling for drug development, cellular therapies for tissue regeneration and regenerative medicine. The partners mutually reinforce and synergistically support the required elements for translation in stem cell medicine: excellence in basic science, capacity building and training, state of the art research infrastructure, clinical and commercial translation capacity, and public engagement.
Importantly, the involvement of these partners ensures a capacity to address childhood and adult disease, pluripotent and tissue stem cell products, and all other areas of stem cell medicine.
Stem cell medicine refers to the development of novel therapies based upon the application of stem cells. This encompasses stem cell-based cellular therapies and regenerative medicine, novel therapies identified via the use of human stem cell-derived tissue models, and gene editing to develop novel cell types.